1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TGOLN1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression EXP 6480464 1 more ... CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO RGD:620445 6480464 1-Naphthylisothiocyanate results in decreased expression of TGOLN2 mRNA CTD PMID:30723492 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:620445 6480464 Tetrachlorodibenzodioxin results in increased expression of TGOLN1 mRNA, Tetrachlorodibenzodioxin results in increased expression of TGOLN2 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TGOLN1 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1351226 6480464 Tetrachlorodibenzodioxin results in increased expression of TGOLN2 mRNA CTD PMID:23397585 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TGOLN1 mRNA CTD PMID:21570461 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1351226 6480464 Triiodothyronine results in increased expression of TGOLN2 mRNA CTD PMID:23397585 3,3',5-triiodo-L-thyronine decreases expression ISO RGD:1351226 6480464 Triiodothyronine results in decreased expression of TGOLN2 mRNA CTD PMID:23397585 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of TGOLN1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO RGD:620445 6480464 Propylthiouracil results in decreased expression of TGOLN1 mRNA CTD PMID:24780913 acetamide decreases expression ISO RGD:620445 6480464 acetamide results in decreased expression of TGOLN2 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1351226 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of TGOLN2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of TGOLN2 mRNA CTD PMID:32699268 all-trans-retinoic acid affects expression ISO RGD:1351226 6480464 Tretinoin affects the expression of TGOLN2 mRNA CTD PMID:15498508 alpha-pinene multiple interactions ISO RGD:1351226 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of TGOLN2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of TGOLN2 mRNA CTD PMID:32699268 amiodarone increases expression ISO RGD:1351226 6480464 Amiodarone results in increased expression of TGOLN2 mRNA CTD PMID:23397585 ammonium chloride affects expression ISO RGD:620445 6480464 Ammonium Chloride affects the expression of TGOLN1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1351226 6480464 Antirheumatic Agents results in decreased expression of TGOLN2 mRNA CTD PMID:24449571 arsenous acid decreases expression ISO RGD:1351226 6480464 Arsenic Trioxide results in decreased expression of TGOLN2 mRNA CTD PMID:20458559 benzene decreases expression ISO RGD:1351226 6480464 Benzene results in decreased expression of TGOLN2 mRNA CTD PMID:15929907 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of TGOLN1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:1351226 6480464 Benzoapyrene results in decreased methylation of TGOLN2 3' UTR CTD PMID:27901495 benzo[a]pyrene affects expression EXP 6480464 Benzoapyrene affects the expression of TGOLN2 mRNA CTD PMID:22342234 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1351226 6480464 7 more ... CTD PMID:20018196 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of TGOLN1 mRNA, Mustard Gas results in increased expression of TGOLN2 mRNA CTD PMID:15674844 bisphenol A increases expression ISO RGD:620445 6480464 bisphenol A results in increased expression of TGOLN2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:620445 6480464 bisphenol A results in decreased expression of TGOLN2 mRNA CTD PMID:30816183 butanal decreases expression ISO RGD:1351226 6480464 butyraldehyde results in decreased expression of TGOLN2 mRNA CTD PMID:26079696 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of TGOLN1 mRNA CTD PMID:24067728 cadmium dichloride decreases expression ISO RGD:1351226 6480464 Cadmium Chloride results in decreased expression of TGOLN2 mRNA, Cadmium Chloride results in decreased expression of TGOLN2 protein CTD PMID:23397585 , PMID:24527689 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chloroquine affects localization ISO RGD:1351226 6480464 Chloroquine affects the localization of TGOLN2 protein CTD PMID:29940786 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of TGOLN1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TGOLN1 mRNA] CTD PMID:17585979 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of TGOLN1 mRNA, Clofibrate results in increased expression of TGOLN2 mRNA CTD PMID:23811191 copper(II) sulfate increases expression ISO RGD:1351226 6480464 Copper Sulfate results in increased expression of TGOLN2 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1351226 6480464 Cyclosporine results in decreased expression of TGOLN2 mRNA CTD PMID:25562108 diarsenic trioxide decreases expression ISO RGD:1351226 6480464 Arsenic Trioxide results in decreased expression of TGOLN2 mRNA CTD PMID:20458559 dimethoate increases expression ISO RGD:1351226 6480464 Dimethoate results in increased expression of TGOLN2 mRNA CTD PMID:23397585 doxorubicin decreases expression ISO RGD:1351226 6480464 Doxorubicin results in decreased expression of TGOLN2 mRNA CTD PMID:29803840 elemental selenium multiple interactions ISO RGD:1351226 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of TGOLN2 mRNA CTD PMID:19244175 enzacamene increases expression ISO RGD:1351226 6480464 enzacamene results in increased expression of TGOLN2 mRNA CTD PMID:23397585 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of TGOLN1 mRNA CTD PMID:30319688 fenvalerate increases expression ISO RGD:620445 6480464 fenvalerate results in increased expression of TGOLN2 mRNA CTD PMID:30307764 finasteride increases expression ISO RGD:620445 6480464 Finasteride results in increased expression of TGOLN2 mRNA CTD PMID:24136188 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of TGOLN1 mRNA CTD PMID:28329830 flurbiprofen increases expression EXP 6480464 Flurbiprofen results in increased expression of TGOLN2 mRNA CTD PMID:16949054 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TGOLN1 mRNA CTD PMID:22206623 gentamycin increases expression ISO RGD:620445 6480464 Gentamicins results in increased expression of TGOLN2 mRNA CTD PMID:22061828 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of TGOLN1 mRNA CTD PMID:21829687 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of TGOLN1 mRNA CTD PMID:25270620 leflunomide increases expression ISO RGD:620445 6480464 leflunomide results in increased expression of TGOLN2 mRNA CTD PMID:24136188 methapyrilene decreases expression ISO RGD:620445 6480464 Methapyrilene results in decreased expression of TGOLN2 mRNA CTD PMID:30467583 methimazole increases expression ISO RGD:1351226 6480464 Methimazole results in increased expression of TGOLN2 mRNA CTD PMID:23397585 methoxychlor decreases expression ISO RGD:1351226 6480464 Methoxychlor results in decreased expression of TGOLN2 mRNA CTD PMID:23397585 methyl methanesulfonate increases expression ISO RGD:1351226 6480464 Methyl Methanesulfonate results in increased expression of TGOLN2 mRNA CTD PMID:23649840 Methylazoxymethanol acetate increases expression ISO RGD:620445 6480464 Methylazoxymethanol Acetate results in increased expression of TGOLN2 mRNA CTD PMID:28349193 nickel sulfate decreases expression ISO RGD:1351226 6480464 nickel sulfate results in decreased expression of TGOLN2 mRNA CTD PMID:18651567 ozone increases expression EXP 6480464 Ozone results in increased expression of TGOLN2 mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:1351226 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of TGOLN2 mRNA more ... CTD PMID:32699268 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of TGOLN1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TGOLN1 mRNA] CTD PMID:17585979 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of TGOLN2 mRNA CTD PMID:17562736 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of TGOLN1 mRNA CTD PMID:23091169 pirinixic acid increases expression ISO RGD:620445 6480464 pirinixic acid results in increased expression of TGOLN1 mRNA CTD PMID:19162173 , PMID:22484513 pirinixic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of TGOLN2 mRNA] CTD PMID:20059764 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of TGOLN1 mRNA, pirinixic acid results in increased expression of TGOLN2 mRNA CTD PMID:17426115 more ... pyrogallol increases expression EXP 6480464 Pyrogallol results in increased expression of TGOLN1 mRNA CTD PMID:20362636 rotenone increases expression ISO RGD:620445 6480464 Rotenone results in increased expression of TGOLN2 mRNA CTD PMID:28374803 selenium atom multiple interactions ISO RGD:1351226 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of TGOLN2 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:620445 6480464 Silicon Dioxide results in increased expression of TGOLN2 mRNA CTD PMID:22431001 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of TGOLN2 protein CTD PMID:28918527 tamibarotene affects expression ISO RGD:1351226 6480464 tamibarotene affects the expression of TGOLN2 mRNA CTD PMID:15498508 tert-butyl hydroperoxide decreases expression ISO RGD:1351226 6480464 tert-Butylhydroperoxide results in decreased expression of TGOLN2 mRNA CTD PMID:15336504 testosterone enanthate affects expression ISO RGD:1351226 6480464 testosterone enanthate affects the expression of TGOLN2 mRNA CTD PMID:17440010 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of TGOLN1 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of TGOLN1 mRNA CTD PMID:27339419 , PMID:31919559 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of TGOLN1 mRNA, titanium dioxide results in increased expression of TGOLN2 mRNA CTD PMID:23409001 , PMID:23557971 torcetrapib increases expression ISO RGD:1351226 6480464 torcetrapib results in increased expression of TGOLN2 mRNA CTD PMID:23228038 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of TGOLN1 mRNA CTD PMID:28973697 uranium atom affects expression ISO RGD:1351226 6480464 Uranium affects the expression of TGOLN2 mRNA CTD PMID:15672453 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of TGOLN1 mRNA CTD PMID:20546886 valproic acid increases expression ISO RGD:1351226 6480464 Valproic Acid results in increased expression of TGOLN2 mRNA CTD PMID:23179753 more ... valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of TGOLN2 mRNA CTD PMID:17292431 , PMID:17963808 vinclozolin affects expression ISO RGD:620445 6480464 vinclozolin affects the expression of TGOLN2 mRNA CTD PMID:19015723 vitamin E decreases expression ISO RGD:1351226 6480464 Vitamin E results in decreased expression of TGOLN2 mRNA CTD PMID:19244175 vitamin E multiple interactions ISO RGD:1351226 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of TGOLN2 mRNA CTD PMID:19244175